Latest Breaking News On - Atul verma - Page 4 : comparemela.com

Research Shows Reduction in Hard-to-Reach Ventricular Tachycardias

Research Shows Reduction in Hard-to-Reach Ventricular Tachycardias
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Czech republicEuropean society of cardiologyMcgill university health centreEuropean societyAtul verma

First-in-human study demonstrates reduction of hard-to-reach ventricular tachycardias

First-in-human study demonstrates reduction of hard-to-reach ventricular tachycardias
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Czech republicMcgill university health centreEuropean society of cardiologyEuropean societyAtul verma

Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study

VANCOUVER, British Columbia, April 02, 2024 Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today the successful completion of enrollment in the paroxysmal cohort of the pivotal PULSAR IDE (Investigational Device Exemption) study. This achievement marks a significant milestone in the journey to bring this groundbreaking technology to patients in the United States, with

British columbiaUnited statesNew yorkUnited kingdomKevin chaplinStefan avallVivek reddyKardium incMcgill university health centreDrug administrationInvestigational device exemptionPre market approvalGlobe systemMount sinai hospitalAtul vermaGlobe catheter

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

Adagio Medical, Inc., a leading innovator in catheter ablation technologies for ventricular tachycardia ("VT") and atrial fibrillation ("AF"), today announced CE Mark approval of its ultra-low temperature cryoablation ("ULTC") system for the treatment of monomorphic ventricular tachycardia. The system consists of the upgraded cryoablation console, also capable of supporting atrial ablation procedures using commercially available iCLAS™ catheters, and the vCLAS™ ventricular cryoablation catheter

United statesLaguna hillsNew yorkOlav bergheimJulian chunBoris schmidtAdagio medical or aja holdco incAdagio medical incJournal of american college cardiologySciences acquisition corpCompany doExchange commissionCardiovascular center bethanienAmerican collegeClinical electrophysiologyBreaking clinical science

Adagio Medical, Inc : Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

Adagio Medical, Inc : Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLaguna hillsOlav bergheimJulian chunDennis riedlBoris schmidtSciences acquisition corpAdagio medical incJournal of american college cardiologyAdagio medical or aja holdco incCardiovascular center bethanienPrnewswire adagio medical incCompany doExchange commissionEuropean heart rhythm association